These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2996343)

  • 1. Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapy.
    Williams GH; Hollenberg NK
    Am J Med; 1985 Sep; 79(3C):3-9. PubMed ID: 2996343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
    Taylor T; Moore TJ; Hollenberg NK; Williams GH
    Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1985 Nov; 3(2):S81-7. PubMed ID: 3003304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin and the renal circulation in hypertension.
    Hollenberg NK; Williams GH
    Circulation; 1988 Jun; 77(6 Pt 2):I59-63. PubMed ID: 3286047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered sodium perception in essential hypertensive patients following rapid volume expansion.
    Conlin P; Moore T; Williams G; Hollenberg N
    J Hum Hypertens; 1999 Oct; 13(10):701-6. PubMed ID: 10516741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel adrenal and renal abnormalities in young patients with essential hypertension.
    Williams GH; Tuck ML; Sullivan JM; Dluhy RG; Hollenberg NK
    Am J Med; 1982 Jun; 72(6):907-14. PubMed ID: 7091162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and endocrine response to saline infusion in essential hypertension.
    Rydstedt LL; Williams GH; Hollenberg NK
    Hypertension; 1986 Mar; 8(3):217-22. PubMed ID: 3005169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renal response to converting enzyme inhibition and the treatment of sodium-sensitive hypertension.
    Hollenberg NK; Williams GH
    Clin Exp Hypertens A; 1987; 9(2-3):531-41. PubMed ID: 3038417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-sensitive hypertension. Implications of pathogenesis for therapy.
    Hollenberg NK; Williams GH
    Am J Hypertens; 1989 Oct; 2(10):809-15. PubMed ID: 2679776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid modulation of renal and adrenal responsiveness to angiotensin II.
    Conlin PR; Moore TJ; Williams GH; Hollenberg NK
    Hypertension; 1993 Dec; 22(6):832-8. PubMed ID: 7503952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
    Bauer JH; Reams GP
    Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II.
    Hollenberg NK; Moore T; Shoback D; Redgrave J; Rabinowe S; Williams GH
    Am J Med; 1986 Sep; 81(3):412-8. PubMed ID: 3752141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.